Sign In
Buy CYN
$1.14
-0.0300 (-2.56%)
At Close: Jul 20, 2026
Cyngn To Present at the HC Wainwright 25th Annual Global Investment Conference on September 11, 2023
07:00am, Monday, 21'st Aug 2023
MENLO PARK, Calif. , Aug. 21, 2023 /PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN), a developer of AI-powered autonomous driving solutions for industrial applications, today an
Cyngn To Present at the Emerging Growth Conference on September 6, 2023
07:00am, Friday, 18'th Aug 2023
MENLO PARK, Calif. , Aug. 18, 2023 /PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN), a developer of AI-powered autonomous driving solutions for industrial applications, today anno
Cyngn Inc. (CYN) Q2 2023 Earnings Call Transcript
08:32pm, Wednesday, 09'th Aug 2023
Cyngn Inc. (NASDAQ:CYN ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Ben Mimmack - Head, Investor Relations Lior Tal - Chairman & Chief Executive Officer Don Alvare
Cyngn Inc. (CYN) Reports Q2 Loss, Tops Revenue Estimates
06:59pm, Wednesday, 09'th Aug 2023
Cyngn Inc. (CYN) came out with a quarterly loss of $0.19 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago.
Cyngn ($CYN) Working to Transform Industrial Vehicles into AI-Powered Autonomous Robots
12:07pm, Thursday, 15'th Jun 2023
Cyngn Inc. (NASDAQ: CYN), a company specializing in autonomous driving software solutions for industrial applications, and BYD have announced significant progress in developing autonomous forklifts us
Cyngn Inc. (CYN) Q1 2023 Earnings Call Transcript
11:11am, Sunday, 14'th May 2023
Cyngn Inc. (NASDAQ:CYN ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Ben Mimmack - Head, Investor Relations Lior Tal - Chairman and Chief Executive Officer Don Alvare
Cyngn Inc. (CYN) Q4 2022 Earnings Call Transcript
08:03pm, Wednesday, 15'th Mar 2023
Cyngn Inc. (NASDAQ:CYN ) Q4 2022 Earnings Conference Call March 15, 2023 4:30 PM ET Company Participants Ben Mimmack - Head of Investor Relations Lior Tal - Chairman & CEO Donald Alvarez - CFO & Direc
Cyngn Announces Date for Fiscal Fourth Quarter and Year-End 2022 Financial Results
07:00am, Wednesday, 08'th Mar 2023
MENLO PARK, Calif.--(BUSINESS WIRE)--Cyngn, Inc. (the “Company” or “Cyngn”) (NASDAQ: CYN), a developer of innovative autonomous driving software solutions for industrial applications, will ann
New Strong Buy Stocks for January 18th
09:47am, Wednesday, 18'th Jan 2023
DTEGY, CYN, OKTA, HOWL and ONCY have been added to the Zacks Rank #1 (Strong Buy) List on January 18, 2022.
Cyngn to Participate in the Sidoti Small Cap Virtual Conference
08:05am, Wednesday, 30'th Nov 2022
MENLO PARK, Calif.--( BUSINESS WIRE )--Cyngn Inc. (“Cyngn” or the “Company”) (NASDAQ: CYN), a developer of innovative autonomous driving software solutions for industrial and commercial applic
Cyngn to Participate in Upcoming Investor Conferences
08:05am, Wednesday, 23'rd Nov 2022
MENLO PARK, Calif.--( BUSINESS WIRE )--Cyngn Inc. (“Cyngn” or the “Company”) (NASDAQ: CYN), a developer of innovative autonomous driving software solutions for industrial and commercial applic
CYNGN, Inc. (CYN) Q3 2022 Earnings Call Transcript
08:53pm, Saturday, 12'th Nov 2022
CYNGN, Inc. (NASDAQ:CYN ) Q3 2022 Earnings Conference Call November 9, 2022 5:00 PM ET Company Participants Carolyne Sohn - The Equity Group Lior Tal - Chairman & CEO Donald Alvarez - CFO & Director B
Cyngn Schedules 2022 Third Quarter Financial Results Release and Conference Call
08:05am, Tuesday, 01'st Nov 2022
MENLO PARK, Calif.
Cyngn to Present at the LD Micro Main Event XV
08:05am, Wednesday, 12'th Oct 2022
Presentation on Tuesday, October 25th at 10:30 a.m. PTMenlo Park, California--(Newsfile Corp. - October 12, 2022) - Cyngn Inc. (NASDAQ: CYN) ("Cyngn" or the "Company"), a developer of innovative auton
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
07:54am, Friday, 19'th Aug 2022 Benzinga
Gainers
Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.
Plus Therapeutics, Inc. (NASDAQ: PSTV) shares climbed 53.9% to close at $0.8480
after the co
